5AM Venture Management’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.5M | Sell |
772,477
-550,000
| -42% | -$11M | 5.96% | 4 |
|
|
2025
Q1 | $26M | Sell |
1,322,477
-307,288
| -19% | -$6.05M | 9.84% | 2 |
|
|
2024
Q4 | $36.7M | Sell |
1,629,765
-122,409
| -7% | -$2.75M | 8.75% | 2 |
|
|
2024
Q3 | $44.8M | Sell |
1,752,174
-858,701
| -33% | -$21.9M | 9.25% | 2 |
|
|
2024
Q2 | $61M | Sell |
2,610,875
-1,225,100
| -32% | -$28.6M | 13.65% | 3 |
|
|
2024
Q1 | $67.5M | Sell |
3,835,975
-1,325,000
| -26% | -$23.3M | 15.11% | 1 |
|
|
2023
Q4 | $71.4M | Hold |
5,160,975
| – | – | 18.95% | 1 |
|
|
2023
Q3 | $70.5M | Sell |
5,160,975
-637,500
| -11% | -$8.71M | 20.29% | 1 |
|
|
2023
Q2 | $118M | Hold |
5,798,475
| – | – | 29.48% | 1 |
|
|
2023
Q1 | $127M | Buy |
+5,798,475
| New | +$127M | 32.47% | 1 |
|